Institutional Ownership
Reviva Pharmaceutcls Hldgs I
CUSIP 76152G209COM NEWQ1 2026
13D / 13G Filings
0
Schedule 13D/13G on record
Beneficial Filers
0
Distinct reporting persons
Largest Stake
—
Max % of class reported
Institutional Holders
32
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Millennium Management LLC | 793.9K | $579.3K |
| 2 | Highbridge Capital Management LLC | 762.2K | $556.2K |
| 3 | Armistice Capital, LLC | 592.1K | $432.0K |
| 4 | Warberg Asset Management LLC | 90.8K | $66.2K |
| 5 | Geode Capital Management, LLC | 73.0K | $53.3K |
| 6 | Renaissance Technologies LLC | 43.0K | $31.4K |
| 7 | State Street Corp | 19.2K | $14.0K |
| 8 | Blackrock, Inc. | 18.6K | $13.6K |
| 9 | Castleview Partners, LLC | 15.7K | $11.5K |
| 10 | Two Sigma Investments, LP | 10.7K | $7.8K |